DKK 121.0
(0.83%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 2.68 Million | 5.52 Million | -898 Thousand | 2.9 Million | 1.68 Million | - |
Net Income | 33.63 Million | 25.17 Million | 23.74 Million | 14.73 Million | 27.23 Million | 16.52 Million |
Depreciation & Amortization | 1.34 Million | 2.76 Million | -449 Thousand | 1.45 Million | 844 Thousand | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -33.63 Million | -25.17 Million | -23.74 Million | -14.73 Million | -27.23 Million | -16.52 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | 2.68 Million | 5.52 Million | -898 Thousand | 2.9 Million | 1.68 Million | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 2.68 Million | 5.52 Million | -898 Thousand | 2.9 Million | 1.68 Million | - |
Free Cash Flow | 2.68 Million | 5.52 Million | -898 Thousand | 2.9 Million | 1.68 Million | - |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 9.2 Million | 10.42 Million | 33.63 Million | 9.21 Million | 7.34 Million | 6.64 Million |
Depreciation & Amortization | - | 365 Thousand | 1.34 Million | 318 Thousand | 337 Thousand | 320 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -9.2 Million | -10.42 Million | -33.63 Million | -9.21 Million | -7.34 Million | -6.64 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | - | - |
Cash at end of period | - | 730 Thousand | 2.68 Million | 636 Thousand | 674 Thousand | 640 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | 730 Thousand | 2.68 Million | 636 Thousand | 674 Thousand | 640 Thousand |
Free Cash Flow | - | 730 Thousand | 2.68 Million | 636 Thousand | 674 Thousand | 640 Thousand |
FNCNF
JPASSOCIAT
0848
000623
EVOK
NGRD3